table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Cancer Biopsy Market Size Analysis from 2022 to 2027
1.5.1 Global Cancer Biopsy Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Cancer Biopsy Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Cancer Biopsy Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Cancer Biopsy Industry Impact
Chapter 2 Global Cancer Biopsy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cancer Biopsy (Volume and Value) by Type
2.1.1 Global Cancer Biopsy Consumption and Market Share by Type (2016-2021)
2.1.2 Global Cancer Biopsy Revenue and Market Share by Type (2016-2021)
2.2 Global Cancer Biopsy (Volume and Value) by Application
2.2.1 Global Cancer Biopsy Consumption and Market Share by Application (2016-2021)
2.2.2 Global Cancer Biopsy Revenue and Market Share by Application (2016-2021)
2.3 Global Cancer Biopsy (Volume and Value) by Regions
2.3.1 Global Cancer Biopsy Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Cancer Biopsy Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Cancer Biopsy Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Cancer Biopsy Consumption by Regions (2016-2021)
4.2 North America Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
4.10 South America Cancer Biopsy Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Cancer Biopsy Market Analysis
5.1 North America Cancer Biopsy Consumption and Value Analysis
5.1.1 North America Cancer Biopsy Market Under COVID-19
5.2 North America Cancer Biopsy Consumption Volume by Types
5.3 North America Cancer Biopsy Consumption Structure by Application
5.4 North America Cancer Biopsy Consumption by Top Countries
5.4.1 United States Cancer Biopsy Consumption Volume from 2016 to 2021
5.4.2 Canada Cancer Biopsy Consumption Volume from 2016 to 2021
5.4.3 Mexico Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 6 East Asia Cancer Biopsy Market Analysis
6.1 East Asia Cancer Biopsy Consumption and Value Analysis
6.1.1 East Asia Cancer Biopsy Market Under COVID-19
6.2 East Asia Cancer Biopsy Consumption Volume by Types
6.3 East Asia Cancer Biopsy Consumption Structure by Application
6.4 East Asia Cancer Biopsy Consumption by Top Countries
6.4.1 China Cancer Biopsy Consumption Volume from 2016 to 2021
6.4.2 Japan Cancer Biopsy Consumption Volume from 2016 to 2021
6.4.3 South Korea Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 7 Europe Cancer Biopsy Market Analysis
7.1 Europe Cancer Biopsy Consumption and Value Analysis
7.1.1 Europe Cancer Biopsy Market Under COVID-19
7.2 Europe Cancer Biopsy Consumption Volume by Types
7.3 Europe Cancer Biopsy Consumption Structure by Application
7.4 Europe Cancer Biopsy Consumption by Top Countries
7.4.1 Germany Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.2 UK Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.3 France Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.4 Italy Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.5 Russia Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.6 Spain Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.7 Netherlands Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.8 Switzerland Cancer Biopsy Consumption Volume from 2016 to 2021
7.4.9 Poland Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 8 South Asia Cancer Biopsy Market Analysis
8.1 South Asia Cancer Biopsy Consumption and Value Analysis
8.1.1 South Asia Cancer Biopsy Market Under COVID-19
8.2 South Asia Cancer Biopsy Consumption Volume by Types
8.3 South Asia Cancer Biopsy Consumption Structure by Application
8.4 South Asia Cancer Biopsy Consumption by Top Countries
8.4.1 India Cancer Biopsy Consumption Volume from 2016 to 2021
8.4.2 Pakistan Cancer Biopsy Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Cancer Biopsy Market Analysis
9.1 Southeast Asia Cancer Biopsy Consumption and Value Analysis
9.1.1 Southeast Asia Cancer Biopsy Market Under COVID-19
9.2 Southeast Asia Cancer Biopsy Consumption Volume by Types
9.3 Southeast Asia Cancer Biopsy Consumption Structure by Application
9.4 Southeast Asia Cancer Biopsy Consumption by Top Countries
9.4.1 Indonesia Cancer Biopsy Consumption Volume from 2016 to 2021
9.4.2 Thailand Cancer Biopsy Consumption Volume from 2016 to 2021
9.4.3 Singapore Cancer Biopsy Consumption Volume from 2016 to 2021
9.4.4 Malaysia Cancer Biopsy Consumption Volume from 2016 to 2021
9.4.5 Philippines Cancer Biopsy Consumption Volume from 2016 to 2021
9.4.6 Vietnam Cancer Biopsy Consumption Volume from 2016 to 2021
9.4.7 Myanmar Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 10 Middle East Cancer Biopsy Market Analysis
10.1 Middle East Cancer Biopsy Consumption and Value Analysis
10.1.1 Middle East Cancer Biopsy Market Under COVID-19
10.2 Middle East Cancer Biopsy Consumption Volume by Types
10.3 Middle East Cancer Biopsy Consumption Structure by Application
10.4 Middle East Cancer Biopsy Consumption by Top Countries
10.4.1 Turkey Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.3 Iran Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.5 Israel Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.6 Iraq Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.7 Qatar Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.8 Kuwait Cancer Biopsy Consumption Volume from 2016 to 2021
10.4.9 Oman Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 11 Africa Cancer Biopsy Market Analysis
11.1 Africa Cancer Biopsy Consumption and Value Analysis
11.1.1 Africa Cancer Biopsy Market Under COVID-19
11.2 Africa Cancer Biopsy Consumption Volume by Types
11.3 Africa Cancer Biopsy Consumption Structure by Application
11.4 Africa Cancer Biopsy Consumption by Top Countries
11.4.1 Nigeria Cancer Biopsy Consumption Volume from 2016 to 2021
11.4.2 South Africa Cancer Biopsy Consumption Volume from 2016 to 2021
11.4.3 Egypt Cancer Biopsy Consumption Volume from 2016 to 2021
11.4.4 Algeria Cancer Biopsy Consumption Volume from 2016 to 2021
11.4.5 Morocco Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 12 Oceania Cancer Biopsy Market Analysis
12.1 Oceania Cancer Biopsy Consumption and Value Analysis
12.2 Oceania Cancer Biopsy Consumption Volume by Types
12.3 Oceania Cancer Biopsy Consumption Structure by Application
12.4 Oceania Cancer Biopsy Consumption by Top Countries
12.4.1 Australia Cancer Biopsy Consumption Volume from 2016 to 2021
12.4.2 New Zealand Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 13 South America Cancer Biopsy Market Analysis
13.1 South America Cancer Biopsy Consumption and Value Analysis
13.1.1 South America Cancer Biopsy Market Under COVID-19
13.2 South America Cancer Biopsy Consumption Volume by Types
13.3 South America Cancer Biopsy Consumption Structure by Application
13.4 South America Cancer Biopsy Consumption Volume by Major Countries
13.4.1 Brazil Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.2 Argentina Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.3 Columbia Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.4 Chile Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.5 Venezuela Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.6 Peru Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Cancer Biopsy Consumption Volume from 2016 to 2021
13.4.8 Ecuador Cancer Biopsy Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Cancer Biopsy Business
14.1 Qiagen N.V.
14.1.1 Qiagen N.V. Company Profile
14.1.2 Qiagen N.V. Cancer Biopsy Product Specification
14.1.3 Qiagen N.V. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Danaher
14.2.1 Danaher Company Profile
14.2.2 Danaher Cancer Biopsy Product Specification
14.2.3 Danaher Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Myriad Genetics
14.3.1 Myriad Genetics Company Profile
14.3.2 Myriad Genetics Cancer Biopsy Product Specification
14.3.3 Myriad Genetics Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Illumina, Inc.
14.4.1 Illumina, Inc. Company Profile
14.4.2 Illumina, Inc. Cancer Biopsy Product Specification
14.4.3 Illumina, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Thermo Fisher Scientific, Inc.
14.5.1 Thermo Fisher Scientific, Inc. Company Profile
14.5.2 Thermo Fisher Scientific, Inc. Cancer Biopsy Product Specification
14.5.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 ANGLE Plc
14.6.1 ANGLE Plc Company Profile
14.6.2 ANGLE Plc Cancer Biopsy Product Specification
14.6.3 ANGLE Plc Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 GRAIL, Inc.
14.7.1 GRAIL, Inc. Company Profile
14.7.2 GRAIL, Inc. Cancer Biopsy Product Specification
14.7.3 GRAIL, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Biocept, Inc.
14.8.1 Biocept, Inc. Company Profile
14.8.2 Biocept, Inc. Cancer Biopsy Product Specification
14.8.3 Biocept, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Hologic, Inc.
14.9.1 Hologic, Inc. Company Profile
14.9.2 Hologic, Inc. Cancer Biopsy Product Specification
14.9.3 Hologic, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Lucence Diagnostics Pte. Ltd.
14.10.1 Lucence Diagnostics Pte. Ltd. Company Profile
14.10.2 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Specification
14.10.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Chronix Biomedical, Inc.
14.11.1 Chronix Biomedical, Inc. Company Profile
14.11.2 Chronix Biomedical, Inc. Cancer Biopsy Product Specification
14.11.3 Chronix Biomedical, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Guardant Health
14.12.1 Guardant Health Company Profile
14.12.2 Guardant Health Cancer Biopsy Product Specification
14.12.3 Guardant Health Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Personal Genome Diagnostics Inc.
14.13.1 Personal Genome Diagnostics Inc. Company Profile
14.13.2 Personal Genome Diagnostics Inc. Cancer Biopsy Product Specification
14.13.3 Personal Genome Diagnostics Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 Oncimmune
14.14.1 Oncimmune Company Profile
14.14.2 Oncimmune Cancer Biopsy Product Specification
14.14.3 Oncimmune Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.15 Exact Sciences Corporation
14.15.1 Exact Sciences Corporation Company Profile
14.15.2 Exact Sciences Corporation Cancer Biopsy Product Specification
14.15.3 Exact Sciences Corporation Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.16 Freenome Holdings, Inc.
14.16.1 Freenome Holdings, Inc. Company Profile
14.16.2 Freenome Holdings, Inc. Cancer Biopsy Product Specification
14.16.3 Freenome Holdings, Inc. Cancer Biopsy Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Cancer Biopsy Market Forecast (2022-2027)
15.1 Global Cancer Biopsy Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Cancer Biopsy Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Cancer Biopsy Value and Growth Rate Forecast (2022-2027)
15.2 Global Cancer Biopsy Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Cancer Biopsy Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Cancer Biopsy Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Cancer Biopsy Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Cancer Biopsy Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Cancer Biopsy Consumption Forecast by Type (2022-2027)
15.3.2 Global Cancer Biopsy Revenue Forecast by Type (2022-2027)
15.3.3 Global Cancer Biopsy Price Forecast by Type (2022-2027)
15.4 Global Cancer Biopsy Consumption Volume Forecast by Application (2022-2027)
15.5 Cancer Biopsy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
